NASDAQ Composite opens in less than thirteen hours and Arena Pharmaceuticals’s pre-market value is already 1.78% up.

The last session, NASDAQ Composite finished with Arena Pharmaceuticals rising 2.87% to $80.56. NASDAQ Composite slid 0.12% to $13,112.64, following last session’s downward trend on what was a somewhat rough trend trading session.

Arena Pharmaceuticals’s last close was $78.31, 11.95% below its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the current quarter and 155.7% for the next. The company’s growth estimates for the present quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $80.56 at 20:36 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is way above its 50-day moving average of $72.38 and way above its 200-day moving average of $71.02.


Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 1.71%, 0.48%, and 0.59%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 7.15%, 4.71%, and 3.72%, respectively.


Please enter your comment!
Please enter your name here